Study of Lanreotide to Treat Polycystic Kidney Disease (DIPAK1)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Leiden University Medical Center
Erasmus Medical Center
Radboud University
Information provided by (Responsible Party):
dr. R.T. Gansevoort, University Medical Centre Groningen
ClinicalTrials.gov Identifier:
NCT01616927
First received: June 6, 2012
Last updated: May 27, 2015
Last verified: May 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2017
  Estimated Primary Completion Date: August 2017 (Final data collection date for primary outcome measure)